📰 Josh Bartch News

Josh Bartch News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Josh Bartch. Real-time updates on events, politics, business and more.

Mydecine Provides Q4 2023 Business Update

October 26, 2023

VANCOUVER, British Columbia, Oct. 26, 2023 -- Mydecine Innovations Group Inc. , a biotechnology company engineering the next wave of innovative medications and treatment protocols to directly...

United States United Kingdom British Columbia Josh Bartch Joshua Bartch Steve Cohen

Source: marketscreener.com

Mydecine Innovations Group Announces Admission to Trading on the AQSE Growth Market in London, UK

October 12, 2023

VANCOUVER, British Columbia, Oct. 12, 2023 -- Mydecine Innovations Group, Inc. , a biotechnology company engineering the next wave of innovative medications and treatment protocols to directly...

United States British Columbia United Kingdom Neil Stevenson Moore Josh Bartch David Coffman George Duxberry

Source: marketscreener.com

Mydecine Innovations Group Announces Admission to Trading

October 10, 2023

The Company has completed its admission to the Access segment of the AQSE Growth Market and trading will commence at 8:00 A.M. GM - Oct 10, 2023 -

United Kingdom British Columbia United States David Coffman George Duxberry Josh Bartch Neil Stevenson Moore

Source: globenewswire.com

Mydecine Innovations Group Announces Expected U.K. Dual Listing Admission Date

September 27, 2023

VANCOUVER, British Columbia, Sept. 27, 2023 (GLOBE NEWSWIRE) —

Josh Bartch

Source: financialpost.com

Mydecine Innovations Group Announces Expected U.K. Dual

September 27, 2023

VANCOUVER, British Columbia, Sept. 27, 2023 (GLOBE NEWSWIRE) -- Mydecine Innovations Group Inc. (“Mydecine” or the “Company”) (NEO:MYCO) (OTC:MYCOF)...

United States British Columbia United Kingdom Joshua Bartch Josh Bartch University Of Alberta

Source: globenewswire.com

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Mydecine Innovations Group Closes Sale of Its Wholly-Owned

December 12, 2022

DENVER, Dec. 12, 2022 (GLOBE NEWSWIRE) -- Mydecine Innovations Group Inc. (“Mydecine” or the “Company”) (NEO:MYCO) (OTC:MYCOF) (FSE:0NFA) a biotechnology...

United States United Kingdom Pangenomic Nara Josh Bartch Maryam Marissen Joshua Bartch

Source: globenewswire.com

Mydecine Innovations Group Announces Common Share Subscription Agreement

August 29, 2022

29.08.2022 - DENVER, Aug. 29, 2022 (GLOBE NEWSWIRE) - Mydecine Innovations Group Inc. (Mydecine or the Company) (NEO:MYCO) (OTC:MYCOF) (FSE:0NFA), a biotechnology company engineering the next wave of innovative medications and treatment protocols to ... Seite 1

United States Josh Bartch Mydecine Innovations Group Inc Company The Common Company The Investor Shelf Prospectus

Source: wallstreet-online.de

U.S. FDA Clears MYCO-001 for Multi-Site Government Funded

June 17, 2022

DENVER, June 17, 2022 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company”), a biotechnology...

United States Morgan Kervitsky Jessica Riggleman Josh Bartch Michaelp Bogenschutz Peter Hendricks

Source: globenewswire.com

U.S. FDA Clears MYCO-001 for Multi-Site Government Funded Trial in Smoking Cessation

June 17, 2022

17.06.2022 - DENVER, June 17, 2022 (GLOBE NEWSWIRE) - Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company”), a biotechnology aiming to transform the treatment of mental health and addiction disorders, today announced ... Seite 1

Jessica Riggleman Michaelp Bogenschutz Peter Hendricks Josh Bartch Matthew Johnson Regulatory Affairs

Source: wallstreet-online.de